Viridian Therapeutics宣布上调2032年到期1.75%可转换优先票据与普通股同步公开发行规模,募资总额达3.5亿美元

美股速递
May 07

Viridian Therapeutics, Inc. (简称:Viridian Therapeutics) 正式公布其同步公开发行方案的最新定价细节。此次发行包含2032年到期的1.75%可转换优先票据及公司普通股,且发行规模较原计划有所扩大。经调整后,两项发行的募资总额合计达到3.5亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10